EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19

EMA’s human medicines committee (CHMP) has issued advice on the use of Lagevrio (also known as molnupiravir or MK 4482) for the treatment of COVID-19. The medicine, which is currently not authorised in the EU, can be used to treat adults with COVID-19 who do not require supplemental oxygen and who


Click to view: Cyprus Vaccination News - Live

Article automatically added to our system on Monday, November 22, 2021

EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19


Contents of this article including associated images are © PIO (Official) 2022
Views & opinions expressed are those of the author and/or PIO (Official) .

Article Tags: #issues   #advice   #lagevrio   #molnupiravir   #treatment   #covid  


  • Click Here For Cyprus Properties For Sale
Advertise Here

  Popular Today

  • Click Here For Cyprus Properties For Sale

  Trending Cyprus News